1. Home
  2. COOK vs CRBU Comparison

COOK vs CRBU Comparison

Compare COOK & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Traeger Inc.

COOK

Traeger Inc.

HOLD

Current Price

$0.91

Market Cap

184.8M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.86

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COOK
CRBU
Founded
1985
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.8M
203.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
COOK
CRBU
Price
$0.91
$1.86
Analyst Decision
Hold
Strong Buy
Analyst Count
7
3
Target Price
$2.04
$9.33
AVG Volume (30 Days)
675.8K
1.1M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$582,799,000.00
$9,295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.66
52 Week High
$3.31
$3.54

Technical Indicators

Market Signals
Indicator
COOK
CRBU
Relative Strength Index (RSI) 53.62 43.28
Support Level $0.71 $1.75
Resistance Level $0.84 $1.96
Average True Range (ATR) 0.09 0.11
MACD 0.01 0.02
Stochastic Oscillator 60.08 60.02

Price Performance

Historical Comparison
COOK
CRBU

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: